State of Wisconsin Investment Board’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-31,186
Closed -$466K 2672
2022
Q4
$466K Buy
+31,186
New +$432K ﹤0.01% 1924
2019
Q2
Sell
-13,890
Closed -$114K 1642
2019
Q1
$114K Buy
13,890
+3,170
+30% +$32.7K ﹤0.01% 1499
2018
Q4
$172K Buy
10,720
+120
+1% +$2.64K ﹤0.01% 1463
2018
Q3
$351K Buy
+10,600
New +$272K ﹤0.01% 1450

State of Wisconsin Investment Board's AVEO Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 31,186 shares — an estimated $466K sold.

State of Wisconsin Investment Board first reported a position in AVEO in Q3 2018 and held it in 4 quarters. The position peaked at $466K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • State of Wisconsin Investment Board reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 31,186 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $466K.
  • State of Wisconsin Investment Board first reported a position in AVEO Pharmaceuticals, Inc. in Q3 2018 and held it in 4 quarters.
  • State of Wisconsin Investment Board's AVEO Pharmaceuticals, Inc. position peaked at $466K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.